Professional Practice Advisories

Pharmacists need to understand the risks and benefits of brown bagging medications in order to make informed decisions on the appropriateness of a brown bagging program.

Collaborative drug therapy management (CDTM) is a formal partnership between a pharmacist and physician or group of pharmacists and physicians to allow the pharmacist(s) to manage a patient's drug therapy.

Practice Advisory on Drug Coverage Parity presents issues that arise when contemplating benefit design drug coverage parity issues.

This practice advisory identifies several different ways to manage specialty drugs and many questions that should be answered when evaluating specialty drug benefits. 

Professional Practice Advisory on Tablet Splitting address concerns of managed health care systems and guidelines that should be in place to determine which medications may be appropriate for tablet splitting. 

Practice Advisory on the Impact of GINA to Managed Care Pharmacy identify many questions that have arisen about the implications of GINA on the practice of managed care pharmacy.

Prescription and over-the-counter (OTC) drug manufacturers are required to complete the Food and Drug Administration’s (FDA) approval process prior to marketing; however, for various reasons, there are currently medications marketed, prescribed and dispensed without this approval.